News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
487,876 Results
Type
Article (8070)
Company Profile (143)
Press Release (479663)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166781)
Career Advice (304)
Deals (25744)
Drug Delivery (7)
Drug Development (52911)
Employer Resources (14)
FDA (9764)
Job Trends (8577)
News (238249)
Policy (17898)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (8)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (3)
2027 Genetown Elite (2)
2027 Genetown Premier (1)
2027 Genetown Standard (2)
2027 Pharm Country Digital (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (495)
Accelerated approval (29)
ADA (18)
Adcomms (1)
Allergies (100)
Alliances (33167)
ALS (118)
Alzheimer's disease (994)
Antibody-drug conjugate (ADC) (320)
Approvals (10472)
Artificial intelligence (358)
ASCO (160)
Autoimmune disease (235)
Automation (33)
Bankruptcy (263)
Belgium (4)
Best Places to Work (6960)
BIO (36)
Biologics (33)
BIOSECURE Act (1)
Biosimilars (123)
BioSpace Insights (17)
Biotechnology (89)
Bispecific (14)
Bladder cancer (143)
Brain cancer (35)
Breast cancer (538)
Cancer (3968)
Cardiovascular disease (236)
Career advice (245)
Career pathing (1)
CAR-T (184)
CDC (1)
CDMO (28)
Celiac Disease (3)
Cell therapy (507)
Cervical cancer (36)
Clinical research (48406)
Collaboration (1356)
Commercialization (22)
Compensation (1607)
Complete response letters (36)
COVID-19 (775)
CRISPR (68)
C-suite (849)
Cystic fibrosis (89)
Data (6272)
Denatured (4)
Depression (108)
Dermatology (95)
Diabetes (377)
Diagnostics (4254)
Digital health (40)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (169)
Drug pricing (7)
Drug shortages (3)
Duchenne muscular dystrophy (174)
Earnings (73921)
Editorial (1)
Employer branding (2)
Employer resources (14)
ESMO (188)
Events (88665)
Executive appointments (735)
Eye disease (3)
FDA (12663)
Fibrodysplasia Ossificans Progressiva (11)
Fragile X (1)
Friedreich's ataxia (19)
Frontotemporal dementia (25)
Funding (992)
Gene editing (132)
Generative AI (13)
Gene therapy (350)
GLP-1 (310)
Government (949)
Grass and pollen (2)
Guidances (281)
Healthcare (9390)
Hematology (94)
HIV (56)
Huntington's disease (26)
Idiopathic pulmonary fibrosis (5)
IgA nephropathy (78)
Immunology and inflammation (113)
Immuno-oncology (70)
Indications (177)
Infectious disease (976)
Inflammatory bowel disease (141)
Inflation Reduction Act (4)
Influenza (87)
Intellectual property (270)
Interviews (41)
IPO (12398)
IRA (2)
Job creations (1970)
Job search strategy (235)
JPM (1)
Kidney cancer (19)
Kidney disease (77)
Layoffs (59)
Legal (5195)
Licensing (46)
Liver cancer (46)
Longevity (25)
Lung cancer (575)
Lung diease (8)
Lymphoma (266)
Machine learning (30)
Management (3)
Manufacturing (615)
Marketing (19)
MASH (121)
Medical affairs (2)
Medical device (8710)
Medtech (8889)
Mergers & acquisitions (14454)
Metabolic disorders (764)
mRNA (71)
Multiple sclerosis (115)
Multispecific (2)
NASH (4)
Netherlands (2)
Neurodegenerative disease (240)
Neuropsychiatric disorders (40)
Neuroscience (1931)
Neurotech (2)
NextGen: Class of 2026 (3152)
Non-profit (844)
Obesity (240)
Opinion (11)
Ovarian cancer (177)
Pain (189)
Pancreatic cancer (230)
Parkinson's disease (217)
Partnered (12)
Patents (522)
Patient advocacy (2)
Patient recruitment (548)
Patient selection (36)
Peanut (33)
People (41512)
Peptides (14)
Pharmaceutical (30)
Pharmacy benefit managers (10)
Phase 1 (15625)
Phase 2 (21632)
Phase 3 (14608)
Pipeline (8342)
Policy (18)
Postmarket research (1570)
Preclinical (6592)
Press Release (34)
Prostate cancer (203)
Psychedelics (10)
Radiopharmaceuticals (203)
Rare diseases (621)
Real estate (3027)
Recruiting (6)
Regenerative medicine (12)
Regulatory (15167)
Reports (23)
Research institute (590)
Resumes & cover letters (45)
Rett syndrome (46)
RNA editing (9)
RSV (49)
Schizophrenia (109)
Series A (173)
Series B (126)
Service/supplier (5)
Sickle cell disease (65)
Spinal muscular atrophy (92)
Sponsored (5)
Startups (2021)
Stem cells (1)
Stomach cancer (4)
Substance use disorders (16)
Supply chain (54)
Tariffs (1)
Vaccines (351)
Venture capital (17)
Weight loss (78)
Wet AMD (3)
Women's health (98)
Date
Last 7 days (390)
Last 30 days (1523)
Last 365 days (19098)
2026 (15426)
2025 (19258)
2024 (23001)
2023 (26542)
2022 (34594)
2021 (37189)
2020 (33471)
2019 (23261)
2018 (17474)
2017 (18769)
2016 (17925)
2015 (24267)
2014 (21680)
2013 (18136)
2012 (20221)
2011 (20441)
2010 (20332)
Location
Africa (231)
Alabama (80)
Alaska (2)
Arizona (319)
Arkansas (12)
Asia (18049)
Australia (2117)
California (12838)
Canada (3351)
China (571)
Colorado (526)
Connecticut (445)
Delaware (224)
Europe (24809)
Florida (1928)
Georgia (405)
Hawaii (3)
Idaho (46)
Illinois (765)
India (59)
Indiana (331)
Iowa (18)
Japan (452)
Kansas (104)
Kentucky (33)
Louisiana (28)
Maine (27)
Maryland (1272)
Massachusetts (8401)
Michigan (321)
Minnesota (593)
Mississippi (4)
Missouri (84)
Montana (20)
Nebraska (11)
Nevada (132)
New Hampshire (60)
New Jersey (2825)
New Mexico (12)
New York (3006)
North Carolina (1363)
North Dakota (4)
Northern California (6504)
Ohio (304)
Oklahoma (15)
Oregon (17)
Pennsylvania (2388)
Puerto Rico (24)
Rhode Island (31)
South America (407)
South Carolina (81)
South Dakota (1)
Southern California (5345)
Tennessee (128)
Texas (2117)
United States (41599)
Utah (391)
Vermont (1)
Virginia (166)
Washington D.C. (39)
Washington State (985)
West Virginia (1)
Wisconsin (81)
Wyoming (1)
487,876 Results for "agenus inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Agenus to Provide Third Quarter 2026 Financial Report and Development Update
October 23, 2026
·
4 min read
Press Releases
Agenus to Participate in Chardan’s 10th Annual Healthcare Investor Conference
October 12, 2026
·
2 min read
Press Releases
Agenus to Participate in Upcoming September 2026 Investor Conferences
August 31, 2026
·
2 min read
Cell therapy
Agenus cancer cocktail records 0% response rate, missing midstage goal
An investigational cocktail was tied to a 0% overall response rate in patients with gastroesophageal cancer, but developers Agenus and MiNK Therapeutics aren’t giving up on the program just yet.
April 20, 2026
·
2 min read
·
Gabrielle Masson
Press Releases
Armenia Grants First Marketing Authorizations for Agenus’ BOT+BAL in Previously Treated MSS Metastatic Colorectal Cancer
October 8, 2026
·
8 min read
Press Releases
Agenus Reports 48% Estimated Three-Year Survival With BOT+BAL in Recurrent Ovarian Cancer at IGCS 2026
October 5, 2026
·
9 min read
Press Releases
Agenus to Present BOT+BAL Long-Term Survival Data and Translational Research With agenT-797 in Colorectal Cancer at SITC 2026
October 3, 2026
·
4 min read
Press Releases
Agenus to Provide Second Quarter 2026 Financial Report and Development Update
July 29, 2026
·
3 min read
Press Releases
Agenus Announces Virtual 2026 Annual Shareholders Meeting
June 3, 2026
·
1 min read
Press Releases
Agenus to Present Three-Year Overall Survival Data for BOT+BAL in Recurrent Ovarian Cancer at IGCS 2026
September 10, 2026
·
4 min read
1 of 48,788
Next
